News Releases
News Releases
-
Aug 2, 2018Ships 21 systems including 12 SRT-100 Vision™ systems
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT),...
-
Aug 2, 2018SRT-100+ Offers Advanced Features for Patients and Doctors, Including Remote Diagnostics and Patient Medical Records Integration, as Well as Core System Enhancements
Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radiation...
-
Jul 31, 2018Sensus Also Named Runner-Up "Company Innovator of the Year"
Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radiation...
-
Jul 24, 2018
Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT),...
-
Jul 12, 2018SkinCure Provides Turnkey Solution for Sensus' SRT-100 Vision™, Aimed at Dermatology Community
Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radiation...
-
Jul 10, 2018
Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), and...
-
Jun 25, 2018
Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT),...
-
Jun 12, 2018
Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT),...
-
May 8, 2018New Executive Leader Brings Extensive Clinical Research, Medical Marketing and Product Launch Experience to the Company
Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT),...
-
May 3, 2018Ships 21 systems with SRT-100 Vision™ systems sales continuing to rise
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT),...
-
May 1, 2018New Addition to Senior Leadership Team Brings 15 Years of Marketing Experience to Supercharge Sensus' Domestic Oncology Efforts
Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT),...
-
Apr 26, 2018
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT),...
-
Apr 19, 2018EVP Rick Golin Assumes New Role Bringing Superficial Radiation Therapy to International Distributors in Asia, the Americas, Europe and the Middle East
Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT),...
-
Mar 8, 2018
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), and...
-
Mar 5, 2018Lasers Address Acne Lesion Correction, Hair Removal and Tattoo Removal, Among Other Applications
Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT),...
-
Feb 7, 2018
Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT),...
-
Feb 5, 2018
Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT),...
-
Feb 1, 2018Ninth consecutive quarter of double-digit year-over-year revenue growth
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT),...
-
Jan 25, 2018
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT),...
-
Jan 8, 2018Sensus and Chindex Medical Begin Shipping SRT-100 Units to Treat Keloid Patients
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today...
-
Nov 2, 2017Marks eighth consecutive quarter of double-digit year-over-year revenue growth
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT),...
-
Nov 1, 2017
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT),...
-
Oct 31, 2017
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT),...
-
Oct 25, 2017
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and keloids with Superficial Radiation Therapy (SRT), announces that...
-
Oct 23, 2017Collaboration Brings Sensus Healthcare's SRT Technology and Stratpharma's Wound Care Medical Devices Together to Advance Radiation Patient Outcomes
Stratpharma Inc. USA, a U.S. subsidiary of Stratpharma AG, the Swiss company that specializes in innovative film-forming full-contact topical medical products to improve medical and aesthetic...